T. Rowe Price Associates
SYRE icon

T. Rowe Price Associates’s Spyre Therapeutics SYRE Stock Holding History

T. Rowe Price Associates’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$13.9M Buy
2025
Q1 		$4.01M Sell
2024
Q4 		$11.8M Buy
2024
Q3 		$12.6M Buy
2024
Q2 		$7.24M Buy
2024
Q1 		$2.98M Buy